Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ralph A Tripp

Showing results (11-20 of 238) with videos related to

Pageof 24
Sort By:
Viral Immunology|April 15, 2020
Peter C. Doherty: A Legacy of MentoringRalph A Tripp, John Stambas
Journal of Virology|September 27, 2008
RNA interference inhibits respiratory syncytial virus replication and disease pathogenesis without inhibiting priming of the memory immune responseWenliang Zhang, Ralph A Tripp
Viruses|April 30, 2021
Intervention Strategies for Seasonal and Emerging Respiratory Viruses with Drugs and Vaccines Targeting Viral Surface GlycoproteinsRalph A Tripp, John Stambas
Viruses|November 25, 2023
Screening Drugs for Broad-Spectrum, Host-Directed Antiviral Activity: Lessons from the Development of Probenecid for COVID-19Ralph A Tripp, David E Martin
Viruses|December 28, 2021
Immunopathology of RSV: An Updated ReviewHarrison C Bergeron, Ralph A Tripp
Vaccines|September 11, 2019
Original Antigenic Sin and Respiratory Syncytial Virus VaccinesRalph A Tripp, Ultan F Power
Viruses|March 26, 2022
Repurposing Probenecid to Inhibit SARS-CoV-2, Influenza Virus, and Respiratory Syncytial Virus (RSV) ReplicationRalph A Tripp, David E Martin
Viruses|January 25, 2018
Verdinexor Targeting of CRM1 is a Promising Therapeutic Approach against RSV and Influenza VirusesJennifer A Pickens, Ralph A Tripp
Current Topics in Microbiology and Immunology|July 11, 2014
Antiviral effects of inhibiting host gene expressionRalph A Tripp, S Mark Tompkins
Vaccines|December 6, 2016
Synthetic Biodegradable Microparticle and Nanoparticle Vaccines against the Respiratory Syncytial VirusPatricia A Jorquera, Ralph A Tripp
Pageof 24

Showing results (11-20 of 238) with videos related to

Sort By:
Pageof 24
Viral Immunology|April 15, 2020
Peter C. Doherty: A Legacy of MentoringRalph A Tripp, John Stambas
Journal of Virology|September 27, 2008
RNA interference inhibits respiratory syncytial virus replication and disease pathogenesis without inhibiting priming of the memory immune responseWenliang Zhang, Ralph A Tripp
Viruses|April 30, 2021
Intervention Strategies for Seasonal and Emerging Respiratory Viruses with Drugs and Vaccines Targeting Viral Surface GlycoproteinsRalph A Tripp, John Stambas
Viruses|November 25, 2023
Screening Drugs for Broad-Spectrum, Host-Directed Antiviral Activity: Lessons from the Development of Probenecid for COVID-19Ralph A Tripp, David E Martin
Viruses|December 28, 2021
Immunopathology of RSV: An Updated ReviewHarrison C Bergeron, Ralph A Tripp
Vaccines|September 11, 2019
Original Antigenic Sin and Respiratory Syncytial Virus VaccinesRalph A Tripp, Ultan F Power
Viruses|March 26, 2022
Repurposing Probenecid to Inhibit SARS-CoV-2, Influenza Virus, and Respiratory Syncytial Virus (RSV) ReplicationRalph A Tripp, David E Martin
Viruses|January 25, 2018
Verdinexor Targeting of CRM1 is a Promising Therapeutic Approach against RSV and Influenza VirusesJennifer A Pickens, Ralph A Tripp
Current Topics in Microbiology and Immunology|July 11, 2014
Antiviral effects of inhibiting host gene expressionRalph A Tripp, S Mark Tompkins
Vaccines|December 6, 2016
Synthetic Biodegradable Microparticle and Nanoparticle Vaccines against the Respiratory Syncytial VirusPatricia A Jorquera, Ralph A Tripp
Pageof 24